EUVIMEDEUVIMED entdecken
Open Access

Acute and 28‐Day Toxicity Evaluation of New Pleuromutilin Derivative 4g

He-Chao Zhang, Zhun Li, Zhe Qin, Wen-Bo Ge iD, Ya-Jun Yang, Jian-Yong Li iD

Journal of Applied Toxicology · 2026

DOI: 10.1002/jat.70104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von He-Chao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China. Hauptthemen laut MEDLINE: Diterpenes, Anti-Bacterial Agents, Liver. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Technology Innovation Project of CAAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel pleuromutilin derivative, compound 4g with a cyclobutyl side chain, was identified and found to have good antibacterial activity, including methicillin‐resistant Staphylococcus aureus (MRSA) and Mycoplasma . In order to evaluate its safety profile, acute and 28‐day oral toxicity studies were carried out. An acute toxicity study in rats revealed that the oral LD 50 of 4g exceeded 5000 mg/kg, indicating that the compound had low acute toxicity. In a 28‐day oral toxicity test, the rats were repeatedly administered 0, 300, 1000, and 3000 mg/kg doses and showed no adverse clinical symptoms or death. Although 4g did not affect body weight, hematological findings indicated dose‐dependent inflammatory changes at 1000 and 3000 mg/kg. Serum biochemistry showed decreases in alanine aminotransferase (ALT) and alkaline phosphatase (ALP), suggesting adaptive metabolic responses rather than classic hepatocellular injury. Significantly, dose‐dependent increases in relative liver weight were observed at all dose levels, accompanied by minimal hepatocyte steatosis and altered serum lipid profiles, identifying the liver as a primary target organ. Based on the totality of findings, the no‐observed‐adverse‐effect level (NOAEL) was determined to be 300 mg/kg. In conclusion, pleuromutilin derivative 4g has low toxicity, which provides the theoretical basis to further investigate for a new candidate drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesAnti-Bacterial AgentsLiverAnimalsPleuromutilinsMalePolycyclic CompoundsToxicity Tests, AcuteFemaleNo-Observed-Adverse-Effect LevelDose-Response Relationship, DrugRatsLethal Dose 50Administration, OralAlanine TransaminaseRats, Sprague-Dawley

Stichwörter der Autor:innen

28‐day oral toxicityacute toxicityantibacterial activitypleuromutilin derivative

Substanzen

PleuromutilinsDiterpenesPolycyclic CompoundsAnti-Bacterial AgentsAlanine Transaminase

Autor:innen und Institutionen

  • College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.
  • Key Laboratory of New Animal Drug of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Science of CAA…

ORCID-Profile: Wen-Bo Ge, Jian-Yong Li

Förderung

  • Science and Technology Innovation Project of CAAS

Zitieren

APA

Zhang, H. C., Li, Z., Qin, Z., Ge, W. B., Yang, Y. J., & Li, J. Y. (2026). Acute and 28‐Day Toxicity Evaluation of New Pleuromutilin Derivative 4g. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70104

Vancouver

Zhang HC, Li Z, Qin Z, Ge WB, Yang YJ, Li JY. Acute and 28‐Day Toxicity Evaluation of New Pleuromutilin Derivative 4g. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70104

BibTeX
@article{Zhang2026,
  author = {Zhang, He-Chao and Li, Zhun and Qin, Zhe and Ge, Wen-Bo and Yang, Ya-Jun and Li, Jian-Yong},
  title = {Acute and 28‐Day Toxicity Evaluation of New Pleuromutilin Derivative 4g},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  doi = {10.1002/jat.70104}
}
Kostenlos starten →